These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34410679)

  • 1. A Duet Between Histamine and Oleoylethanolamide in the Control of Homeostatic and Cognitive Processes.
    Provensi G; Costa A; Rani B; Blandina P; Passani MB
    Curr Top Behav Neurosci; 2022; 59():389-410. PubMed ID: 34410679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histaminergic Neurotransmission as a Gateway for the Cognitive Effect of Oleoylethanolamide in Contextual Fear Conditioning.
    Provensi G; Fabbri R; Munari L; Costa A; Baldi E; Bucherelli C; Blandina P; Passani MB
    Int J Neuropsychopharmacol; 2017 May; 20(5):392-399. PubMed ID: 28339575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast Cell-Derived Histamine Regulates Liver Ketogenesis via Oleoylethanolamide Signaling.
    Misto A; Provensi G; Vozella V; Passani MB; Piomelli D
    Cell Metab; 2019 Jan; 29(1):91-102.e5. PubMed ID: 30318340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake.
    Provensi G; Coccurello R; Umehara H; Munari L; Giacovazzo G; Galeotti N; Nosi D; Gaetani S; Romano A; Moles A; Blandina P; Passani MB
    Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11527-32. PubMed ID: 25049422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypophagic factor oleoylethanolamide differentially increases c-fos expression in appetite regulating centres in the brain of wild type and histamine deficient mice.
    Umehara H; Fabbri R; Provensi G; Passani MB
    Pharmacol Res; 2016 Nov; 113(Pt A):100-107. PubMed ID: 27543461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamide.
    Azari EK; Ramachandran D; Weibel S; Arnold M; Romano A; Gaetani S; Langhans W; Mansouri A
    Am J Physiol Regul Integr Comp Physiol; 2014 Jul; 307(2):R167-78. PubMed ID: 24829501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diet-Induced Obesity Disrupts Histamine-Dependent Oleoylethanolamide Signaling in the Mouse Liver.
    Lin L; Mabou Tagne A; Squire EN; Lee HL; Fotio Y; Ramirez J; Zheng M; Torrens A; Ahmed F; Ramos R; Plikus MV; Piomelli D
    Pharmacology; 2022; 107(7-8):423-432. PubMed ID: 35691287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour.
    Sihag J; Jones PJH
    Obes Rev; 2018 Feb; 19(2):178-197. PubMed ID: 29124885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acylethanolamines, anandamide and food intake.
    Hansen HS; Diep TA
    Biochem Pharmacol; 2009 Sep; 78(6):553-60. PubMed ID: 19413995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food intake is inhibited by oral oleoylethanolamide.
    Nielsen MJ; Petersen G; Astrup A; Hansen HS
    J Lipid Res; 2004 Jun; 45(6):1027-9. PubMed ID: 15060091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feeding regulation by oleoylethanolamide synthesized from dietary oleic acid.
    Igarashi M; Iwasa K; Yoshikawa K
    Prostaglandins Leukot Essent Fatty Acids; 2021 Feb; 165():102228. PubMed ID: 33385936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-α, on the management and prevention of obesity.
    Tutunchi H; Saghafi-Asl M; Ostadrahimi A
    Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):543-552. PubMed ID: 31868943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1.
    Wang X; Miyares RL; Ahern GP
    J Physiol; 2005 Apr; 564(Pt 2):541-7. PubMed ID: 15695242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine-deficient mice do not respond to the antidepressant-like effects of oleoylethanolamide.
    Costa A; Cristiano C; Cassano T; Gallelli CA; Gaetani S; Ghelardini C; Blandina P; Calignano A; Passani MB; Provensi G
    Neuropharmacology; 2018 Jun; 135():234-241. PubMed ID: 29596898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dietary fat intake influences the activation of specific hindbrain and hypothalamic nuclei by the satiety factor oleoylethanolamide.
    Romano A; Karimian Azari E; Tempesta B; Mansouri A; Micioni Di Bonaventura MV; Ramachandran D; Lutz TA; Bedse G; Langhans W; Gaetani S
    Physiol Behav; 2014 Sep; 136():55-62. PubMed ID: 24802360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanolamine Produced from Oleoylethanolamide Degradation Contributes to Acetylcholine/Dopamine Balance Modulating Eating Behavior.
    Mennella I; Boudry G; Val-Laillet D
    J Nutr; 2019 Mar; 149(3):362-365. PubMed ID: 30722047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain molecules and appetite: the case of oleoylethanolamide.
    Sarro-Ramírez A; Sánchez-López D; Tejeda-Padrón A; Frías C; Zaldívar-Rae J; Murillo-Rodríguez E
    Cent Nerv Syst Agents Med Chem; 2013 Mar; 13(1):88-91. PubMed ID: 23464987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).
    Guzmán M; Lo Verme J; Fu J; Oveisi F; Blázquez C; Piomelli D
    J Biol Chem; 2004 Jul; 279(27):27849-54. PubMed ID: 15123613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oleoylethanolamide-induced anorexia in rats is associated with locomotor impairment.
    Fedele S; Arnold M; Krieger JP; Wolfstädter B; Meyer U; Langhans W; Mansouri A
    Physiol Rep; 2018 Feb; 6(3):. PubMed ID: 29388342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic Model.
    Ren T; Ma A; Zhuo R; Zhang H; Peng L; Jin X; Yao E; Yang L
    J Pharmacol Exp Ther; 2020 Apr; 373(1):81-91. PubMed ID: 32024803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.